Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    83.83
    +0.26 (+0.31%)
     

  • Bitcoin CAD

    88,035.73
    +255.04 (+0.29%)
     

  • CMC Crypto 200

    1,389.65
    +7.08 (+0.51%)
     

  • GOLD FUTURES

    2,345.30
    +2.80 (+0.12%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,762.75
    +195.25 (+1.11%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

STOCKHOLDER ALERT: Monteverde & Associates Continues its Investigation into the Following Merger

ACCESSWIRE
·3 min read

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Akcea Therapeutics, Inc. (NASDAQ:AKCA), relating to its sale to Ionis Pharmaceuticals, Inc. Under the terms of the agreement, Akcea shareholders will receive $18.15 in cash for each share of Akcea common stock owned. Click here for more information: https://www.monteverdelaw.com/case/akcea-therapeutics-inc. It is free, and there is no cost or obligation to you.

  • Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) relating to its sale to a consortium that includes members of CBMG management and several entities. Under the terms of the agreement, CBMG shareholders will receive $19.75 in cash for each share of CBMG stock they own. Click here for more information: https://www.monteverdelaw.com/case/cellular-biomedicine-group-inc-0. It is free, and there is no cost or obligation to you.

  • Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) relating to its sale to Johnson & Johnson. Under the terms of the agreement, MNTA shareholders will receive $52.50 in cash for each share of MNTA stock they own. Click here for more information: https://www.monteverdelaw.com/case/momenta-pharmaceuticals-inc. It is free, and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

ADVERTISEMENT

If you own common stock in any of the above-listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

CONTACT:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/607455/STOCKHOLDER-ALERT-Monteverde-Associates-Continues-its-Investigation-into-the-Following-Merger